| Notes | Unrestricted | Restricted | Total | Total | |
|---|---|---|---|---|---|
| Funds | Funds | Funds | Funds | ||
| 2021-22f | 2021-22f | 2021-22f | 2020-21 f |
||
| Income | |||||
| Charitable activities | |||||
| Course income | 30,250 | 30,250 | 21,575 | ||
| Other income | 330 | 330 | 340 | ||
| Total Income | 30,580 | 30,580 | 21,915 | ||
| Expenditure | |||||
| Charitable activities |
|||||
| Course expenditure | 27,068 | 27,068 | 11,280 | ||
| Donations | 2,550 | 2,550 | 2,600 | ||
| Total | 29,618 | 29,618 | 13,880 | ||
| Other expenditure | |||||
| Support costs | 2,926 | 1,456 | 4,382 | 3,567 | |
| Total Expenditure | 32,544 | 1,456 | 34,000 | 17,447 | |
| Net (Expenditure)/Income | (1,964) | (1,456) | (3,420) | 4,468 | |
| Reconciliation ofFunds | |||||
| Total Funds brought forward | 75,661 | 17,384 | 93,045 | 88,577 | |
| Total Funds carried forward | 7$,697 | 15,928 | 89,625 | 9$,045 |
| 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|
| Notes | Unrestricted | Restricted | Total | Total | |||
| Funds f |
Funds f |
Fundsf | Fundsf | ||||
| Current Assets | |||||||
| Debtors | 852 | 852 | 549 | ||||
| Cash at bank and in | 88,496 | 15,928 | 104,424 | 105,396 | |||
| hand | |||||||
| 89,348 | 15,928 | 105,276 | 105,945 | ||||
| Creditors: | |||||||
| Amounts | falling | (15,651) | (15,651) | (12,900) | |||
| due within | one | ||||||
| year | |||||||
| Net Current | Assets | 73,697 | 15,928 | 89,625 | 93,045 | ||
| Funds | |||||||
| Unrestricted | Funds | 73,697 | 73,697 | 75,661 | |||
| Restricted | Funds | 15,928 | 15,928 | 17,384 | |||
| TotalFunds | 73,697 | 15,928 | 89,625 | 93,045 |
| Surplus/ | |||||
|---|---|---|---|---|---|
| 2021-22 | Income f |
Expense f |
(Oeficit)f | ||
| Prostate Sept 2021 | 4,600 | (3,108) | 1,492 | ||
| Bladder Sept 2021 | 5,100 | (2,608) | 2,492 | ||
| Kidney, Testis &Penis Sept 2021 | 3,000 | (1,955) | 1,045 | ||
| BDIAP/BAUP Symposium | Nov | 2021 | (2,514) | (2,514) | |
| Bladder Jan/Feb 2022 | 4,000 | (1,850) | 2,150 | ||
| Prostate Feb 2022 | 3,900 | (1,850) | 2,050 | ||
| Bladder May 2022 | 9,650 | (13,183) | (3,533) | ||
| Total for Courses 2021-22 | 30,250 | (27,068) | 3,182 | ||
| Total for Courses 2020-21 | 21,575 | (11,280) | 10,295 | ||
| Other income | |||||
| 2021-22 | 2020-21 | ||||
| f | f | ||||
| Full membership subscriptions |
330 | 340 | |||
| haritable activities: Donations | |||||
| 2021-22 | 2020-21 | ||||
| f | f | ||||
| Africa Cancer Action Trust | 1,800 | 2,300 | |||
| The Orchid Cancer Appeal | 750 | 300 | |||
| 2,550 | 2,600 | ||||
| ther Expenditure: Support costs |
|||||
| 2021-22 | 2020-21 | ||||
| f | f | ||||
| Finance: Accounting services |
179 | 392 | |||
| Bank &PayPal Charges | 769 | 686 | |||
| Information Technology |
1,267 | 1,064 | |||
| Other Support Costs | 711 | 668 | |||
| 2,926 | 2,810 | ||||
| Restricted Funds Expenditure |
(Note 11) | 1,456 | 757 | ||
| 4,382 | 3,567 |
| 9 | Creditors: | Amounts | falling due within one year | ||
|---|---|---|---|---|---|
| 2022f | 2021f | ||||
| Deferred | Course Income (Note 10) | 14,900 | 12,900 | ||
| Accruals | 751 | ||||
| 15,651 | 12,900 |
| Deferred | Course income | ||
|---|---|---|---|
| 2022 | 2021 | ||
| f | f | ||
| Balance | at 1September | 12,900 | 5,675 |
| Amounts | added in period |
14,900 | 12,900 |
| Amounts | released to income from | (12,900) | (5,675) |
| previous | periods | ||
| Balance | at31August | 14,900 | 12,900 |
| 2022 | 2021 | |
|---|---|---|
| f | ||
| Balance at 1September | 17,384 | 18,141 |
| EQAexpenditure | (1,456) | (757) |
| 15,928 | 17,384 |